Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

Daiichi Sankyo doses first patients in Phase lll trials for breast cancer

A cluster of breast cancer cells showing visual evidence of programmed cell death. Credit: Annie Cavanagh/Wellcome Images.



Go Top